Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program
Open Access
- 1 June 2017
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (6) , 938-944
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Donor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?Clinical Lymphoma Myeloma and Leukemia, 2016
- New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCTBone Marrow Transplantation, 2015
- Current status of allogeneic transplantation for aggressive non-Hodgkin lymphomaCurrent Opinion in Oncology, 2011
- Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisitedCancer Treatment Reviews, 2010
- Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working PartyJournal of Clinical Oncology, 2007
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1997
- Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell doseBlood, 1993
- Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.Journal of Clinical Oncology, 1993
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990